• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis . Predictors of Nonseroconversion after SARS-CoV-2 Infection

tetano

Editor, Senior Moderator
Emerg Infect Dis


. 2021 Jun 30;27(9).
doi: 10.3201/eid2709.211042. Online ahead of print.
Predictors of Nonseroconversion after SARS-CoV-2 Infection

Weimin Liu, Ronnie M Russell, Frederic Bibollet-Ruche, Ashwin N Skelly, Scott Sherrill-Mix, Drew A Freeman, Regina Stoltz, Emily Lindemuth, Fang-Hua Lee, Sarah Sterrett, Katharine J Bar, Nathaniel Erdmann, Sigrid Gouma, Scott E Hensley, Thomas Ketas, Albert Cupo, Victor M Cruz Portillo, John P Moore, Paul D Bieniasz, Theodora Hatziioannou, Greer Massey, Mary-Beth Minyard, Michael S Saag, Randall S Davis, George M Shaw, William J Britt, Sixto M Leal Jr, Paul Goepfert, Beatrice H Hahn

Abstract

Not all persons recovering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection develop SARS-CoV-2-specific antibodies. We show that nonseroconversion is associated with younger age and higher reverse transcription PCR cycle threshold values and identify SARS-CoV-2 viral loads in the nasopharynx as a major correlate of the systemic antibody response.

Keywords: COVID-19; RT-PCR; SARS-CoV-2; coronavirus disease; cycle threshold; humoral response; nasopharyngeal viral loads; nonseroconversion; respiratory infections; serological nonresponders; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.
 
Back
Top Bottom